Skip to main content

The Role of Public Health Ethics in Vaccine Decision Making: Insights from the Centers for Disease Control and Prevention

  • Chapter
  • First Online:
Vaccinophobia and Vaccine Controversies of the 21st Century

Abstract

Despite the documented public health benefits of immunization, developed countries continue to face threats to public confidence in vaccines. Both vaccine refusal and the more common phenomenon of vaccine hesitancy need to be comprehensively addressed using the tools of science and risk communication. There has also been recognition of the need for greater transparency and acknowledgment of the role of values in vaccine decision making; the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) recently adopted a formal scientific evidence framework in which transparency and values of stakeholders play a central role. Going beyond the use of data, we here discuss the role of public health ethics in supporting vaccine decision making and in broader public discussion of vaccination. The population perspective of the public health ethics approach is contrasted with bioethics which traditionally champions the rights of the individual. The tools of public health ethics, including formal consultations and public engagement processes, can be incorporated into public policy deliberations around vaccines. CDC ethical expertise has added value to ACIP deliberations, most notably in setting policy weighing the risks and benefits of measles, mumps, rubella, and varicella vaccine. Ethicists from the CDC have also been engaged in high-profile public health emergency responses involving vaccination issues, including the 2009 H1N1 influenza pandemic. Just as economic analyses have strengthened discussions centered on scientific evidence in setting policy for vaccines, systematically considering ethics and values can add rigor to the process by which societal input about vaccines occurs. Greater transparency in clarifying the trade-offs made in vaccine decision making can expedite the process of achieving a social consensus on vaccine policy.

The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dawson A. Herd protection as a public good: vaccination and our obligations to others. In: Dawson A, Verweij M, editors. Ethics, prevention and public health. Oxford: Oxford University Press; 2007.

    Google Scholar 

  2. Schwartz JL, Caplan AL. Ethics of vaccination programs. Curr Opin Virol. 2011;1(4):263–7.

    Article  PubMed  Google Scholar 

  3. The January 2012 issue of Virtual Mentor, a monthly ethics journal of the American Medical Association, comprises 11 articles on the topic of “Vaccines and Ethics.” http://virtualmentor.ama-assn.org/2012/01/toc-1201.html. Accessed 15 Nov 2012.

  4. Ethical consideration in HIV preventive vaccine research. UNAIDS guidance document. http://www.who.int/vaccine_research/diseases/hiv/en/JC072-EthicalCons-E.pdf. Accessed 13 Sep 2012.

  5. Ethical considerations arising from vaccine trials conducted in paediatric populations with high disease burden in developing countries. WHO/IVR ethics meeting, 26–28 November, 2002, Accra, Ghana. http://www.who.int/vaccine_research/documents/en/manu774_.pdf. Accessed 13 Sep 2012.

  6. Schwartz J. The first rotavirus vaccine and the politics of acceptable risk. Milbank Q. 2012;90(2):275–310.

    Article  Google Scholar 

  7. Poland GA, Marcuse EK. Developing vaccine policy: attributes of just policy and a proposed template to guide decision and policy making. Vaccine. 2011;29(44):7577–8.

    Article  PubMed  Google Scholar 

  8. Field RI, Caplan AL. Evidence based decision making for vaccines: the need for an ethical foundation. Vaccine. 2012;30(6):1009–13.

    Article  PubMed  Google Scholar 

  9. Lee LM. Public health ethics theory: review and path to convergence. J Law Med Ethics. 2012;40(1):85–98.

    Article  PubMed  Google Scholar 

  10. Childress JF, Faden RR, Gaare RD, Gostin LO, Kahn J, Bonnie RJ, et al. Public health ethics: mapping the terrain. J Law Med Ethics. 2002;30(2):170–8.

    Article  PubMed  Google Scholar 

  11. Callahan D, Jennings B. Ethics and public health: forging a strong relationship. Am J Public Health. 2002;92(2):169–76.

    Article  PubMed  Google Scholar 

  12. Public Health Leadership Society. Principles of the ethical practice of public health. http://www.apha.org/NR/rdonlyres/1CED3CEA-287E-4185-9CBD-BD405FC60856/0/ethicsbrochure.pdf. (2002). Accessed 13 Sep 2012.

  13. The Editors of The Lancet. Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 2010;375(9713):445, ISSN 0140-6736, 10.1016/S0140-6736(10)60175-4. http://www.sciencedirect.com/science/article/pii/S0140673610601754. Accessed 13 Sep 2012.

    Google Scholar 

  14. Omer SB, Enger KS, Moulton LH, Halsey NA, Stokley S, Salmon DA. Geographic clustering of nonmedical exemptions to school immunization requirements and associations with geographic clustering of pertussis. Am J Epidemiol. 2008;168(12):1389–96.

    Article  PubMed  Google Scholar 

  15. Michaels D. Doubt is their product: how industry’s assault on science threatens your health. Oxford: Oxford University Press; 2008.

    Google Scholar 

  16. Rosenau J. Science denial: a guide for scientists. Trends Microbiol. 2012;20(12):567–9.

    Article  PubMed  CAS  Google Scholar 

  17. Washington H. Deadly monopolies: the shocking corporate takeover of life itself—and the consequences for your health and our medical future. New York: Random House, Inc.; 2011.

    Google Scholar 

  18. Washington H. Medical apartheid: the dark history of medical experimentation on black Americans from colonial times to the present. New York: Doubleday; 2006.

    Google Scholar 

  19. Quinn S, Thomas T, Kumar S. The anthrax vaccine and research: reactions from postal workers and public health professionals. Biosecur Bioterror. 2008;6(4):321–33.

    Article  PubMed  Google Scholar 

  20. Bayer R, Fairchild AL. The genesis of public health ethics. Bioethics. 2004;18(6):473–92.

    Article  PubMed  Google Scholar 

  21. Jennings B. Public health and liberty: beyond the Millian paradigm. Public Health Ethics. 2009;2(2):123–34.

    Article  Google Scholar 

  22. Powers M, Faden R, Saghai Y. Liberty, Mill and the framework of public health ethics. Public Health Ethics. 2012;5(1):6–15.

    Article  Google Scholar 

  23. Chen RT, DeStefano F, Pless R, Mootrey G, Kramarz P, Hibbs B. Challenges and controversies in immunization safety. Infect Dis Clin North Am. 2001;15(1):21–39.

    Article  PubMed  CAS  Google Scholar 

  24. Chen RT. Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies. Vaccine. 2004;22:2047–53.

    Article  PubMed  Google Scholar 

  25. Iskander J, Vellozzi C, Gidudu J, Chen RT. Vaccine safety. In: Morrow J, Sheikh N, Schmidt C, Davies H, editors. Vaccinology: principles and practice. 1st ed. Oxford: Blackwell Publishing Ltd; 2012.

    Google Scholar 

  26. Aristotle. The art of rhetoric. In: Lawson-Tancred H, editor. London: Penguin; 1991.

    Google Scholar 

  27. Underwood SM, Powell RL. Religion and spirituality: influence on health/risk behavior and cancer screening behavior of African Americans. ABNF J. 2006;17(1):20–31.

    PubMed  Google Scholar 

  28. World Health Organization. Global Polio Eradication Initiative: strategic plan 2010–2012. Geneva: World Health Organization; 2010. http://www.polioeradication.org/content/publications/gpei.strategicplan.2010-2012.eng.may.2010.pdf. Accessed 28 Jun 2012.

  29. Gust D, Kennedy A, Shui I, Smith P, Nowak G, Pickering L. Parent attitudes toward immunizations and healthcare providers: the role of information. Am J Prev Med. 2005;29(2):105–12.

    Article  PubMed  Google Scholar 

  30. Gigerenzer G. Gut feelings: the intelligence of the unconscious. New York: Viking Penguin; 2007.

    Google Scholar 

  31. MacDonald NE, Smith J, Appleton M. Risk perception, risk management and safety assessment: what can governments do to increase public confidence in their vaccine system? Biologicals. 2012;40(5):384–8.

    Article  PubMed  Google Scholar 

  32. Kirkland A. Creditability battles in the autism litigation. Soc Stud Sci. 2012;42:237–61.

    Article  PubMed  Google Scholar 

  33. Barrett DH, Bernier R, Sowell A. Strengthening public health ethics at the Centers for Disease Control and Prevention. J Public Health Manag Pract. 2008;14(4):348–53.

    PubMed  Google Scholar 

  34. A statement of CDC’s mission and core values is available at http://www.cdc.gov/about/organization/mission.htm. Accessed 7 Jul 2012.

  35. Briss PA, Gostin LO, Gottfried RN, Snider Jr DE. Science and public health policy makers. J Law Med Ethics. 2005;33(4 suppl):89–93.

    PubMed  Google Scholar 

  36. Harris G. U.S. creates ethics panel on priority for flu shots. New York Times. October 28; 2004.

    Google Scholar 

  37. Public Engagement Pilot Project on Pandemic Influenza. Citizen voices on pandemic flu choices. (2005). http://www.hhs.gov/nvpo/PEPPPI/PEPPPICompleteFinalReport.pdf. Accessed 15 May 2012.

  38. Centers for Disease Control and Prevention’s Immunization Safety Office Scientific Agenda. Immunization Safety Office, Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases. (2011). http://www.cdc.gov/vaccinesafety/00_pdf/ISO-Final-Scientific_Agenda-Nov-10.pdf. Accessed 30 Jul 2012.

  39. Information on the Ethics Subcommittee of the Advisory Committee to the Director. http://www.cdc.gov/od/science/integrity/phethics/EthicsSubcommittee/index.htm. Accessed 15 Nov 2012.

  40. Documents available at http://www.cdc.gov/od/science/integrity/phethics/ESdocuments.htm. Accessed 7 Jul 2012. Discussion of travel restrictions document available at http://www.cdc.gov/maso/FACM/pdfs/ACDCDC/2009022526_ACDCDC_ES.pdf. Accessed 7 Jul 2012.

  41. Marin M, Broder KR, Temte JL, Snider DE, Seward JF. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59(RR-3):1–12.

    PubMed  Google Scholar 

  42. Smith JC. The structure, role and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP). Vaccine. 2010;285:A68–75.

    Article  Google Scholar 

  43. Smith JC, Snider DE, Pickering LK. Immunization policy development in the United States: the role of the Advisory Committee on Immunization Practices. Ann Intern Med. 2009;150:45–9.

    Article  PubMed  Google Scholar 

  44. Ahmed F, Temte JL, Campos-Outcalt D, Schünemann HJ. ACIP Evidence Based Recommendation Work Group (EBRWG). Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention. Vaccine. 2011;29(49):9171–6.

    Article  PubMed  Google Scholar 

  45. ACIP Guidance for Health Economics Studies. http://www.cdc.gov/vaccines/recs/acip/downloads/economics-studies-guidance.pdf. Accessed 8 Jul 2012.

  46. Grading of recommendations, assessment, development and evaluation (GRADE) for HPV vaccine for males. MMWR Morb Mortal Wkly Rep. 2011;60(50):1705–8. http://www.cdc.gov/vaccines/acip/recs/GRADE/hpv-vac-males.html. Accessed 15 Nov 2012.

  47. CDC recommendation for Hepatitis B vaccination among adults with diabetes: grading of scientific evidence in support of key recommendations. MMWR Morb Mortal Wkly Rep. 2011;60(50);1709–11. http://www.cdc.gov/vaccines/acip/recs/GRADE/hepB-vac-adults-diabetes.html. Accessed 15 Nov 2012.

  48. Grading of recommendations, assessment, development, and evaluation (GRADE) for pneumococcal vaccines for immunocompromised adults. MMWR Morb Mortal Wkly Rep. 2012;61(40);816–9. http://www.cdc.gov/vaccines/acip/recs/GRADE/pneumo-immuno-adults.html. Accessed 18 Nov 2012.

  49. Additional GRADE information is available at http://www.cdc.gov/vaccines/acip/recs/GRADE/about-grade.html. Accessed 15 Nov 2012.

  50. CDC. Recommendations on the use of quadrivalent Human Papillomavirus Vaccine in males—Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2011;60:1705–8.

    Google Scholar 

  51. CDC. Recommendation for Hepatitis B vaccination among adults with diabetes: grading of scientific evidence in support of key recommendations. MMWR Morb Mortal Wkly Rep. 2011;60(50):1709–11.

    Google Scholar 

  52. Fitch K, Bernstein SJ, Aguilar MS, et al. The RAND/UCLA Appropriateness Method User’s Manual, chapters 6–8. Available at http://www.rand.org/pubs/monograph_reports/MR1269.html. Accessed 13 Sep 2012.

  53. Caplan AL, Schwartz JL. Ethics. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines: expert consult. 5th ed. Philadelphia, PA: Saunders; 2008. p. 1677–83.

    Google Scholar 

  54. Buttenheim A, Jones M, Baras Y. Exposure of California kindergartners to students with personal belief exemptions from mandated school entry vaccinations. Am J Public Health. 2012;102(8):e59–67.

    Article  PubMed  Google Scholar 

  55. Adger WN. Social and ecological resilience: are they related? Prog Hum Geogr. 2000;24:347–64.

    Article  Google Scholar 

  56. Jennings B. Community in public health ethics. In: Ashcroft RE, Dawson A, Draper H, McMillan J, editors. Principles of health care ethics. West Sussex: John Wiley and Sons; 2007.

    Google Scholar 

  57. Jennings B. Public health and civic republicanism. In: Dawson A, Verweij M, editors. Ethics, prevention, and public health. Oxford: Oxford University Press; 2007.

    Google Scholar 

  58. Ruger J. Health and social justice. Oxford: Oxford University Press; 2010.

    Google Scholar 

Download references

Acknowledgments

We acknowledge Robert T. Chen of the CDC National Center for HIV/AIDS, Viral Hepatitis, STD and Tuberculosis Prevention and Walter Orenstein of the Emory University School of Medicine for their perspectives and expertise; Christy Cechman of the CDC Public Health Library and Information Center and Lindsay Kramer of the CDC Public Health Ethics Unit for bibliographic support; and Jane Gidudu of the CDC Office of Scientific Quality and Captain Drue Barrett of the CDC Public Health Ethics Unit for reviews of an earlier draft of this chapter.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leonard Ortmann Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ortmann, L., Iskander, J. (2013). The Role of Public Health Ethics in Vaccine Decision Making: Insights from the Centers for Disease Control and Prevention. In: Chatterjee, A. (eds) Vaccinophobia and Vaccine Controversies of the 21st Century. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7438-8_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7438-8_15

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7437-1

  • Online ISBN: 978-1-4614-7438-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics